Evaluation of common structural brain changes in aging and Alzheimer disease with the use of an MRI-based brain atrophy and lesion index: A comparison between T1WI and T2WI at 1.5T and 3T

American Journal of Neuroradiology

Volumn 35, Issue 3, 2014, Pages 504-512

  Guo, H ^a,b   Song, Xiaowei ^a,c,e   Vandorpe, R ^d,e   Zhang, Y ^b   Chen, W ^a,b   Zhang, N ^a,b   Schmidt, M H ^d,e   Rockwood, K ^c,d,e  

^a IWK HEALTH CENTRE   (Canada)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c DALHOUSIE UNIVERSITY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42];

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN ATROPHY AND LESION INDEX SCORE; CLINICAL DEMENTIA RATING; COGNITIVE DEFECT; COMPARATIVE STUDY; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSIS RELATED GROUP; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOLOGICAL RATING SCALE; SCORING SYSTEM; VALIDATION STUDY; VERY ELDERLY; WHITE MATTER LESION; ATROPHY; BRAIN; PATHOLOGY; PROCEDURES;

AGED; AGING; ALZHEIMER DISEASE; ATROPHY; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING;

EID: 84896483895     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3709     Document Type: Article

References (36)

1. Appel J, Potter E, Bhatia N, et al. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors. AJNR Am J Neuroradiol 2009;30:1870-76
2. Sinka L, Kovari E, Gold G, et al. Small vascular and Alzheimer disease-related pathologic determinants of dementia in the oldest-old. J Neuropathol Exp Neurol 2010;69:1247-55
3. Barnes J, Carmichael OT, Leung KK, et al. Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls. Neurobiol Aging 2013;34:1996-2002
4. Jagust WJ, Zheng L, Harvey DJ, et al. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol 2008;63:72-80 (Pubitemid 351240553)
5. Kim KW, MacFall JR, Payne ME. Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry 2008;64:273-80
6. Black S, Gao F, Bilbao J. Understanding white matter disease: imaging: pathological correlations in vascular cognitive impairment. Stroke 2009;40:S48-52
7. Chen W, Song X, Zhang Y. Assessment of the Virchow-Robin spaces in Alzheimer disease, mild cognitive impairment, and normal aging, using high-field MRI. AJNR Am J Neuroradiol 2011;32:1490-95
8. Kim HJ, Kang SJ, Kim C, et al. The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms: a study among patients with subcortical vascular cognitive impairments. Neurobiol Aging 2013;34:1913-20
9. Duara R, Loewenstein DA, Potter E, et al. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology 2008;71:1986-92
10. Moon WJ, Kim HJ, Roh HG, et al. Atrophy measurement of the anterior commissure and substantia innominata with 3T high-resolution MR imaging: does the measurement differ for patients with frontotemporal lobar degeneration and Alzheimer disease and for healthy subjects? AJNR Am J Neuroradiol 2008;29:1308-13
11. Savva GM, Wharton SB, Ince PG, et al. Age, neuropathology, and dementia. N Engl J Med 2009;360:2302-09
12. Chen W, Song X, Zhang Y, et al. An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal aging. Dement Geriatr Cogn Disord 2010;30:121-30
13. Zhang N, Song X, Zhang Y, et al. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study. J Alzheimers Dis 2011;26:359-67
14. Weiner MW, Aisen PS, Jack CR Jr, et al. The Alzheimer's Disease Neuroimaging Initiative: progress report and future plans. Alzheimers Dement 2010;6:201-11
15. Zhang N, Song X, Zhang Y. Combining structural brain changes improves the prediction of Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 2012;33:318-26
16. Song X, Mitnitski A, Zhang, et al. Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative. J Neurol Neurosurg Psychiatry 2013;84:71-78
17. Alvarez-Linera J. 3T MRI: advances in brain imaging. Eur J Radiol 2008;67:415-26
18. Jack CR Jr, Bernstein MA, Fox NC, et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 2008;27:685-91 (Pubitemid 351508080)
19. Aisen PS, Petersen RC, Donohue MC, et al. Clinical core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement 2010;6:239-46
20. Shaw LM, Vanderstichele H, Knapik-Czajka M, et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 2009;65:403-13
21. Song X, Mitnitski A, Rockwood K. Index variables for studying outcomes in vascular cognitive impairment. Neuroepidemiology 2005;25:196-204 (Pubitemid 41540661)
22. Streiner D, Norman G. Health Measurement Scales: A Practical Guide to Their Development and Use. 4th ed. New York: Oxford University Press; 2008
23. Walter SD, Eliasziw M, Donner A. Sample size and optimal designs for reliability studies. Stat Med 1998;17:101-10 (Pubitemid 28020212)
24. Karas G, Sluimer J, Goekoop R, et al. Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am J Neuroradiol 2008;29:944-49 (Pubitemid 351684972)
25. Frisoni GB, Fox NC, Jack CR Jr, et al. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 2010;6:67-77
26. Agosta F, Pievani M, Sala S, et al. White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 2011;258:853-63
27. Eckerstrom C, Olsson E, Klasson N, et al. High white matter lesion load is associated with hippocampal atrophy in mild cognitive impairment. Dement Geriatr Cogn Disord 2011;31:132-38
28. Raji CA, Lopez OL, Kuller LH, et al. White matter lesions and brain gray matter volume in cognitively normal elders. Neurobiol Aging 2012;33:e7-16
29. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study: pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales: Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study (MRC CFAS). Lancet 2001;357:169-75
30. Launer LJ, Hughes TM, White LR. Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol 2011;70:774-80
31. Gouw AA, van der Flier WM, Pantoni L, et al. On the etiology of incident brain lacunes: longitudinal observations from the LADIS study. Stroke 2008;39:3083-85
32. Jack CR Jr, Shiung MM, Gunter JL, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004;62:591-600 (Pubitemid 38252801)
33. Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet 1996;348:94 -97
34. Shen Q, Loewenstein DA, Potter E, et al. Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease. Alzheimers Dement 2011;7:e101-08
35. Bryan RN, Cai J, Burke G, et al. Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: the atherosclerosis risk in communities study. AJNR Am J Neuroradiol 1999;20:1273-80 (Pubitemid 29400539)
36. Song X, Mitnitski A, MacKnight C, et al. Assessment of individual risk of death using self-report data: an artificial neural network compared with a frailty index. J Am Geriatr Soc 2004;52:1180-84 (Pubitemid 38869080)